SPHK2 and colorectal carcinoma: Importantly, a previous study reports that, miR-363-3p, which impedes CRC cell growth and metastasis by targeting SphK2, is lowly expressed in CRC, and its under-expression is linked to the unfavorable prognosis of the patients [12].